gene silencing

The British CRISPR software developer is turning to investment platform SyndicateRoom as it looks to commercialize its products and expand into the US.

NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has signed a supply and distribution agreement enabling it to offer its customers access to Sirion Biotech's RNAiONE custom short hairpin RNA development services.

Dicerna Pharmaceuticals announced this week that it has taken a non-exclusive license to RNAi intellectual property held by Plant Bioscience Limited.

A study published in Nature Genetics last month has identified a genetic variant strongly associated with higher risk of certain brain tumors, and suggests the involvement of a long non-coding RNA or a microRNA.

Alnylam Pharmaceuticals this week announced that it has taken a non-exclusive license to RNAi-related intellectual property held by UK technology management firm Plant Bioscience Limited.

The company has added respiratory and inflammation to an RNAi screening program that began with oncology.

Papers of Note

Premium

RNAi-Related Papers Published April 2009

People in the News

Premium

Richard Chin, John Rossi, Alice Lin-Tsing, Kenneth Reed

Funding Update

Premium

NSF Microarray Grants Awarded Jan. 1 — March 31

Strands

Premium

Tekmira Pharmaceuticals, MDRNA

Pages

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.